Oklo chief strategy officer Goodwin sells $66,367 in shares

William Carroll Murphy Goodwin, Chief Strategy Officer at Oklo Inc. (NASDAQ:OKLO), sold 1,775 shares of the company’s Class A Common Stock for a total value of $66,367. The shares were sold at a price of $37.39 each on September 28, 2026. The stock has since declined to $26.35, trading near its 52-week low of $26.07, reflecting a challenging year for the nuclear energy company.

The transaction was identified as a "sell to cover" sale, executed to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units (RSUs). This sale does not represent a discretionary transaction by Mr. Goodwin.

Two days prior, on September 26, 2026, Mr. Goodwin acquired 3,294 shares of Class A Common Stock upon the vesting of previously granted RSUs. Each RSU represents a contingent right to receive one share of the Issuer’s Class A Common Stock. These RSUs were granted on November 4, 2025, and vested in full on September 26, 2026.

Following these transactions, Mr. Goodwin directly holds 46,787 shares of Oklo Inc. Class A Common Stock. He also beneficially owns 94,593 restricted stock units. InvestingPro subscribers have access to 17 additional ProTips for OKLO, plus comprehensive Pro Research Reports covering 1,400+ US equities with expert analysis and actionable intelligence.

In other recent news, Oklo Inc. has seen several updates from financial analysts regarding its stock ratings and price targets. Piper Sandler lowered its price target for Oklo to $49 from $55, citing increased capital expenditure estimates for new plants. Despite this adjustment, Piper Sandler maintained its Overweight rating on the stock. Canaccord Genuity reiterated a Buy rating with a $100 price target, noting that revenue from Oklo’s isotope division might remain modest but could exceed expectations as projects like Groves-2 advance. Additionally, Piper Sandler reaffirmed its confidence in Oklo’s reactor progress, maintaining a $55 price target after a visit to the Groves facility. Truist Securities reiterated a Hold rating with a $51 price target, highlighting ongoing development activities across Oklo’s three business segments. Meanwhile, UBS adjusted its price target down to $41 from $55, reflecting updates to its estimates, including higher expected expenses and lower long-term R&D spending. These developments provide investors with varied perspectives on Oklo’s future financial performance.